Literature DB >> 22236005

Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure.

O N Donkor1, M Ravikumar, O Proudfoot, S L Day, V Apostolopoulos, G Paukovics, T Vasiljevic, S L Nutt, H Gill.   

Abstract

The immunomodulatory effects of probiotics were assessed following exposure of normal peripheral blood mononuclear cells (PBMC), cord blood cells and the spleen-derived monocyte/macrophage cell line CRL-9850 to Lactobacillus acidophilus LAVRI-A1, Lb. rhamnosus GG, exopolysaccharides (EPS)-producing Streptococcus thermophilus St1275, Bifidobacteriun longum BL536, B. lactis B94 and Escherichia coli TG1 strains. The production of a panel of pro- and anti-inflammatory cytokines by PBMC following bacterial stimulation was measured, using live, heat-killed or mock gastrointestinal tract (GIT)-exposed bacteria, and results show that (i) all bacterial strains investigated induced significant secretion of pro- and anti-inflammatory cytokines from PBMC-derived monocytes/macrophages; and (ii) cytokine levels increased relative to the expansion of bacterial cell numbers over time for cells exposed to live cultures. Bifidobacteria and S. thermophilus stimulated significant concentrations of transforming growth factor (TGF)-β, an interleukin necessary for the differentiation of regulatory T cells (T(reg) )/T helper type 17 (Th17) cells and, as such, the study further examined the induction of Th17 and T(reg) cells after PBMC exposure to selected bacteria for 96 h. Data show a significant increase in the numbers of both cell types in the exposed populations, measured by cell surface marker expression and by cytokine production. Probiotics have been shown to induce cytokines from a range of immune cells following ingestion of these organisms. These studies suggest that probiotics' interaction with immune-competent cells produces a cytokine milieu, exerting immunomodulatory effects on local effector cells, as well as potently inducing differentiation of Th17 and T(reg) cells.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236005      PMCID: PMC3278695          DOI: 10.1111/j.1365-2249.2011.04496.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

Review 1.  Probiotics to enhance anti-infective defences in the gastrointestinal tract.

Authors:  Harsharnjit S Gill
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-10       Impact factor: 3.043

2.  Interactions between commensal intestinal bacteria and the immune system.

Authors:  Andrew J Macpherson; Nicola L Harris
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

3.  Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria.

Authors:  Martin L Cross; Anja Ganner; Diaa Teilab; Linley M Fray
Journal:  FEMS Immunol Med Microbiol       Date:  2004-10-01

4.  Evaluation of media for selective enumeration of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and bifidobacteria.

Authors:  R I Dave; N P Shah
Journal:  J Dairy Sci       Date:  1996-09       Impact factor: 4.034

5.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

Authors:  D M Klinman; A K Yi; S L Beaucage; J Conover; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

6.  IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses.

Authors:  L Meyaard; E Hovenkamp; S A Otto; F Miedema
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

7.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

Authors:  D J Berg; R Kühn; K Rajewsky; W Müller; S Menon; N Davidson; G Grünig; D Rennick
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Lactobacillus GG bacteria ameliorate arthritis in Lewis rats.

Authors:  Ehud Baharav; Felix Mor; Marisa Halpern; Abraham Weinberger
Journal:  J Nutr       Date:  2004-08       Impact factor: 4.798

9.  Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains.

Authors:  Fang He; Hirotsugu Morita; Arthur C Ouwehand; Masataka Hosoda; Masaru Hiramatsu; Jun-ichi Kurisaki; Erika Isolauri; Yoshimi Benno; Seppo Salminen
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

10.  Expression of mRNA encoding IFN alpha in macrophages stimulated with Lactobacillus gasseri.

Authors:  H Kitazawa; Y Tomioka; K Matsumura; H Aso; M Mizugaki; T Itoh; T Yamaguchi
Journal:  FEMS Microbiol Lett       Date:  1994-07-15       Impact factor: 2.742

View more
  30 in total

1.  Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.

Authors:  Daniel J Merenstein; Tina P Tan; Aleksey Molokin; Keisha Herbin Smith; Robert F Roberts; Nawar M Shara; Mihriye Mete; Mary Ellen Sanders; Gloria Solano-Aguilar
Journal:  Gut Microbes       Date:  2015

2.  rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant.

Authors:  Claudia Petrarca; Emanuela Clemente; Valentina Toto; Manuela Iezzi; Cosmo Rossi; Stefania Zanotta; Gianni Mistrello; Ivan Zanoni; Francesca Granucci; Stefania Arioli; Diego Mora; Simone Guglielmetti; Roberto Paganelli; Mario Di Gioacchino
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

3.  Sulforaphane enhances apoptosis induced by Lactobacillus pentosus strain S-PT84 via the TNFα pathway in human colon cancer cells.

Authors:  Shusuke Yasuda; Mano Horinaka; Toshiyuki Sakai
Journal:  Oncol Lett       Date:  2019-08-14       Impact factor: 2.967

4.  Immunomodulatory Effect of Bifidobacterium, Lactobacillus, and Streptococcus Strains of Paraprobiotics in Lipopolysaccharide-Stimulated Inflammatory Responses in RAW-264.7 Macrophages.

Authors:  Monique Michels; Gabriel Fernandes Alves Jesus; Ana Paula Lorenzen Voytena; Marina Rossetto; Fernanda Ramlov; Emily Córneo; Paulo Feuser; Daniel Gelain; Felipe Dal-Pizzol
Journal:  Curr Microbiol       Date:  2021-12-14       Impact factor: 2.188

5.  Enumeration of Probiotic Strain Lacticaseibacillus rhamnosus GG (ATCC 53103) Using Viability Real-time PCR.

Authors:  Hanan R Shehata; Steven G Newmaster
Journal:  Probiotics Antimicrob Proteins       Date:  2021-09-30       Impact factor: 4.609

6.  Effect and Mechanism of Bifidobacterium animalis B94 in the Prevention and Treatment of Liver Injury in Rats.

Authors:  Tianfang Zhang; Jie Wang; Zhao Yao; Lingmei Ni; Yifan Zhao; Shuang Wei; Zuobing Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-06-29       Impact factor: 6.073

7.  Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli.

Authors:  C Rask; I Adlerberth; A Berggren; I L Ahrén; A E Wold
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

8.  Intestinal Regulatory T Cells.

Authors:  Vanessa R Figliuolo da Paz; Deepa R Jamwal; Pawel R Kiela
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.

Authors:  Sylvia Cruchet; Raquel Furnes; Aldo Maruy; Eduardo Hebel; Jorge Palacios; Fernando Medina; Nelson Ramirez; Marina Orsi; Lysette Rondon; Vera Sdepanian; Luis Xóchihua; Manuel Ybarra; Roberto Arturo Zablah
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

Review 10.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.